Depreciation of Kezar Life Sciences, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Kezar Life Sciences, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Kezar Life Sciences, Inc. Depreciation for the quarter ending 30 Sep 2025 was $200,000, a 33% decline year-over-year.
  • Kezar Life Sciences, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $800,000, a 33% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Depreciation for 2024 was $1,000,000, a 9.1% decline from 2023.
  • Kezar Life Sciences, Inc. annual Depreciation for 2023 was $1,100,000, a 10% increase from 2022.
  • Kezar Life Sciences, Inc. annual Depreciation for 2022 was $1,000,000, a 11% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Kezar Life Sciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $800,000 $200,000 -$100,000 -33% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $900,000 $200,000 -$100,000 -33% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $1,000,000 $300,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $1,000,000 $100,000 -$200,000 -67% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q3 2024 $1,200,000 $300,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $1,200,000 $300,000 +$100,000 +50% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $1,100,000 $300,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $1,100,000 $300,000 +$100,000 +50% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $1,000,000 $300,000 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $1,000,000 $200,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $1,000,000 $300,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $1,000,000 $200,000 $0 0% 01 Oct 2022 31 Dec 2022 10-K 25 Mar 2025 2024 FY
Q3 2022 $1,000,000 $300,000 +$100,000 +50% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $900,000 $200,000 -$100,000 -33% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $1,000,000 $300,000 +$100,000 +50% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $900,000 $200,000 $0 0% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $900,000 $200,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $900,000 $300,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $900,000 $200,000 $0 0% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $900,000 $200,000 -$100,000 -33% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2023 2022 FY
Q3 2020 $1,000,000 $200,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $1,000,000 $300,000 +$100,000 +50% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $900,000 $200,000 $0 0% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q4 2019 $900,000 $300,000 +$100,000 +50% 01 Oct 2019 31 Dec 2019 10-K 17 Mar 2022 2021 FY
Q3 2019 $800,000 $200,000 $0 0% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $800,000 $200,000 $0 0% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $800,000 $200,000 +$100,000 +100% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $700,000 $200,000 01 Oct 2018 31 Dec 2018 10-K 11 Mar 2021 2020 FY
Q3 2018 $200,000 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $200,000 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $100,000 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1

Kezar Life Sciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,000,000 -$100,000 -9.1% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 $1,100,000 +$100,000 +10% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $1,000,000 +$100,000 +11% 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2025 2024 FY
2021 $900,000 $0 0% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $900,000 $0 0% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2023 2022 FY
2019 $900,000 +$200,000 +29% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2022 2021 FY
2018 $700,000 +$500,000 +250% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021 2020 FY
2017 $200,000 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.